Indapta Therapeutics

1 follower


Indapta Therapeutics is a biotechnology company focused on developing and commercializing a proprietary, off-the-shelf, allogeneic FcRγ-deficient natural killer (G-NK) cell therapy to treat multiple types of cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mark W. Frohlich

Collapse
Robert Sikorski
Acting Chief Medical Officer
Austin Bigley
VP, Research
Ronald Martell
Co-Founder, Executive Chairman
Moya Daniels
Regulatory Affairs Consultant